Cambridge Cognition Holdings Plc
Cambridge Cognition Holdings plc

Cambridge Cognition Holdings plc share price, news, views and interviews

Cambridge Cognition Holdings plc (LON:COG) is a world leading neuroscience technology company committed to enhancing global research, accelerating treatment development and improving patient outcomes in conditions affecting brain health by optimising the assessment of cognition.

DRUG Development

DIGITAL Health

COGNITIVE Research

Cambridge Cognition
Cambridge Cognition
Cambridge Cognition

Maximise The Chances Of Success In Clinical Trials

Industry-leading and regulatory-accepted digital products to optimise and accelerate safe, effective and efficient drug development.

  • Enrich clinical trial recruitment
  • Develop new treatments
  • Improve patient outcomes

Assess And Improve Brain Health And Mental Wellbeing

Medical devices and digital health technology to collect real world outcomes data, identify patients, detect impairments early, and track wellbeing over time. 

  • Alzheimer’s screening
  • Cognitive health assessments
  • Mental health at work

The Gold Standard In Cognitive Assessment

The world’s most recognised digital cognitive testing platform for all areas of brain research providing sensitive assessment of cognitive domains in-person and online. 

  • CANTAB cognitive assessments
  • Training and support
  • Neurocience consultancy

Share this page

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp
Cambridge Cognition Holdings Plc

Cambridge Cognition Holdings plc share price

Fundamentals

Latest Cambridge Cognition Holdings plc News

Interviews

Questions & Answers

Broker Notes & Comments

Cambridge Cognition Holdings plc share price

Fundamentals

Share this page

Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on facebook
Facebook
Share on email
Email
Share on whatsapp
WhatsApp

Data policy – All information should be used for indicative purposes only. You should independently check data before making any investment decision and or seek professional advice. DirectorsTalk cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used.